Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer.
Krajewski W, Aumatell J, Subiela JD, Nowak Ł, Tukiendorf A, Moschini M, Basile G, Poletajew S, Małkiewicz B, Del Giudice F, Maggi M, Chung BI, Cimadamore A, Galosi AB, Fave RFD, D'Andrea D, Shariat SF, Hornak J, Babjuk M, Chorbińska J, Teoh JY, Muilwijk T, Joniau S, Tafuri A, Antonelli A, Panunzio A, Alvarez-Maestro M, Simone G, Mastroianni R, Łaszkiewicz J, Lonati C, Zamboni S, Simeone C, Niedziela Ł, Candela L, Macek P, Contieri R, Hidalgo BG, Rivas JG, Sosnowski R, Mori K, Mir C, Soria F, González-Padilla DA, Faba ÒR, Palou J, Ploussard G, Rajwa P, Hałoń A, Laukhtina E, Pradere B, Tully K, Burgos FJ, Cidre MÁJ, Szydełko T; European Association of Urology- Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Krajewski W, et al. Among authors: cidre maj. Urol Oncol. 2022 Nov;40(11):491.e11-491.e19. doi: 10.1016/j.urolonc.2022.06.008. Epub 2022 Jul 16. Urol Oncol. 2022. PMID: 35851185
Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.
Subiela JD, González-Padilla DA, Huguet J, Aumatell J, Rodríguez-Faba O, Krajewski W, Feliu AH, Mínguez C, Plaza JL, Artiles Medina A, Gajate P, Jiménez Cidre MÁ, Burgos Revilla J, Breda A, Palou J. Subiela JD, et al. Urology. 2023 Feb;172:157-164. doi: 10.1016/j.urology.2022.08.064. Epub 2022 Nov 25. Urology. 2023. PMID: 36436672
Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.
Bonfill X, Martinez-Zapata MJ, Vernooij RW, Sánchez MJ, Suárez-Varela MM, de la Cruz J, Emparanza JI, Ferrer M, Pijoán JI, Ramos-Goñi JM, Palou J, Schmidt S, Abraira V, Zamora J; EMPARO-CU study group. Bonfill X, et al. BMC Urol. 2015 Jul 2;15:60. doi: 10.1186/s12894-015-0058-x. BMC Urol. 2015. PMID: 26134117 Free PMC article.
Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation.
Schmidt S, Riel R, Frances A, Lorente Garin JA, Bonfill X, Martinez-Zapata MJ, Morales Suarez-Varela M, dela Cruz J, Emparanza JI, Sánchez MJ, Zamora J, Goñi JM, Alonso J, Ferrer M; EMPARO-CU Study Group. Schmidt S, et al. Health Qual Life Outcomes. 2014 Feb 15;12:20. doi: 10.1186/1477-7525-12-20. Health Qual Life Outcomes. 2014. PMID: 24528506 Free PMC article.
A phase II dose-ranging study of mirabegron in patients with overactive bladder.
Chapple CR, Dvorak V, Radziszewski P, Van Kerrebroeck P, Wyndaele JJ, Bosman B, Boerrigter P, Drogendijk T, Ridder A, Van Der Putten-Slob I, Yamaguchi O; Dragon Investigator Group. Chapple CR, et al. Int Urogynecol J. 2013 Sep;24(9):1447-58. doi: 10.1007/s00192-013-2042-x. Epub 2013 Mar 8. Int Urogynecol J. 2013. PMID: 23471546 Free PMC article. Clinical Trial.